LEUKEMIA, ACUTE LYMPHOBLASTIC
Clinical trials for LEUKEMIA, ACUTE LYMPHOBLASTIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, ACUTE LYMPHOBLASTIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, ACUTE LYMPHOBLASTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against tough leukemia
Disease control OngoingThis study tests a new combination treatment for adults aged 18-65 with a specific, high-risk type of acute lymphoblastic leukemia (ALL) called BCR/ABL1-like. The treatment adds the targeted drug ponatinib to standard chemotherapy. The goal is to see if this approach can make the…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Phase: PHASE2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
New hope for leukemia patients allergic to standard treatment
Disease control NO_LONGER_AVAILABLEThis study offered Erwinase to people with acute lymphoblastic leukemia (ALL) who had allergic reactions to common L-asparaginase drugs. The goal was to provide a safe alternative to continue cancer treatment. Participants were children and adults with ALL and a history of hypers…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated May 15, 2026 12:07 UTC